The abstract is read at the publisher; the summary is JClub's.
Hepatic FoxO1 loss in liver-specific Foxo1 knockdown mice and transgenic zebrafish triggers pancreatic β cell deficiency by inducing apoptosis, linked to increased C18/22/24 ceramides.
- Why it matters: Preserving pancreatic β cells is essential for antihyperglycemic approaches, but how hepatic FoxO1 loss affects β cell homeostasis systemically and through what mechanism is unclear.
- What they did: The study used liver-specific Foxo1 knockdown mice and transgenic zebrafish, combining lipidomics and pharmacology to show liver-derived C18/22/24 ceramides inhibit AKT-mTORC1 signaling in β cells. It also used transcriptional profiling plus ChIP-seq and luciferase assays to show FoxO1 represses Cers2/4, increasing ceramide synthase 2/4 transcription.
- The result: Liver-derived C18/22/24 ceramides are implicated in β cell apoptosis and deficiency after hepatic FoxO1 loss, suggesting an inter-organ signaling axis that could inform β cell–preserving therapies.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.